Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largel...
CEL-SCI's shares dropped 38.19% after announcing a $10 million public offering priced below market value to fund its cancer...
CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE:CVM), a clinical stage cancer immunotherapy company,toda...
CEL-SCI (AMEX:CVM) reported quarterly losses of $(1.36) per share. This is a 67.46 percent increase over losses of $(4.18) per ...
Memorandum of Understanding (MOU) signed with a leading Saudi Arabian pharma company which submitted the Breakthrough Medicine ...
